Sommaire

• • ·Desperate diseases, desperate measures: Tackling malignant hypertension in the 1950s

    Page :197-203

    Hector O. Ventura, Mandeep R. Mehra, Franz H. Messerli

    Résumé Résumé
• • ·Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (⍺IIb/β₃) receptor-directed platelet inhibition

    Page :204-210

    You Fu Li, Frederick A. Spencer, Richard C. Becker

    Résumé Résumé
• • ·The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

    Page :211-217

    Michael A. Blazing, James A. de Lemos, Christopher K. Dyke, Robert M. Califf, David Bilheimer, Eugene Braunwald

    Résumé Résumé
• • ·Introduction

    Page :218-223

    Stephen P. Sanders

    
• • ·Pediatric issues and diseases

    Page :224-228

    Ronald M. Lauer, Stephen P. Sanders

    
• • ·End points for cardiovascular drug trials in pediatric patients

    Page :229-232

    Alan R. Sinaiko, Ronald M. Lauer, Stephen P. Sanders

    
• • ·Ethical issues in pediatric trials

    Page :233-236

    Lainie Friedman Ross, Jane W. Newburger, Stephen P. Sanders

    
• • ·Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)

    Page :237-243

    Ron J.G. Peters, William Spickler, Pierre Théroux, Harvey White, Michael Gibson, Peter G. Molhoek, H.Vernon Anderson, Jeffrey I. Weitz, Jack Hirsh, W.Douglas Weaver

    Résumé Résumé
• • ·A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial

    Page :244-247

    Allan M. Ross, Runlin Gao, Karin S. Coyne, Jilin Chen, Kangbao Yao, Yuejin Yang, Xuewen Qin, Shubin Qiao, Min Yao, for the TUCC Investigators

    Résumé Résumé
• • ·Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis

    Page :248-253

    Abhiram Prasad, Kwang Kon Koh, William H. Schenke, Rita Mincemoyer, Gyorgy Csako, Thomas A. Fleischer, Margaret Brown, Thomas A. Selvaggi, Arshed A. Quyyumi

    Résumé Résumé
• • ·Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort

    Page :254-261

    Michelle M. Graham, Peter D. Faris, William A. Ghali, P.Diane Galbraith, Colleen M. Norris, Jason T. Badry, L.Brent Mitchell, Michael J. Curtis, Merril L. Knudtson, for the APPROACH Investigators

    Résumé Résumé
• • ·Quality of care among elderly patients hospitalized with unstable angina

    Page :263-270

    Chandreshwar N. Shahi, Saif S. Rathore, Yongfei Wang, Ranjana Thakur, Wen-Chih Wu, Jennifer M. Lewis, Marcia K. Petrillo, Martha J. Radford, Harlan M. Krumholz

    Résumé Résumé
• • ·Predictors of quality of life 6 months and 1 year after acute myocardial infarction

    Page :271-279

    Christine A. Beck, Lawrence Joseph, Patrick Bélisle, Louise Pilote, for the QOLAMI Investigators

    Résumé Résumé
• • ·Cardiac conduction abnormalities in endocarditis defined by the Duke criteria

    Page :280-285

    Trip J. Meine, Richard E. Nettles, Deverick J. Anderson, Christopher H. Cabell, G.Ralph Corey, Daniel J. Sexton, Andrew Wang

    Résumé Résumé
• • ·Identification of sinus node dysfunction by use of P-wave signal-averaged electrocardiograms in paroxysmal atrial fibrillation: A prospective study

    Page :286-293

    Takahisa Yamada, Masatake Fukunami, Tsuyoshi Shimonagata, Kazuaki Kumagai, Yoshihiro Asano, Akio Hirata, Mitsutoshi Asai, Masatsugu Hori, Noritake Hoki

    Résumé Résumé
• • ·Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation

    Page :294-300

    Christopher S. Simpson, Raymond Yee, John K. Lee, Marilyn Braney, George J. Klein, Andrew D. Krahn, Allan C. Skanes

    Résumé Résumé
• • ·Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA)

    Page :301-308

    Vladimir Dzavik, Ronald G. Carere, G.B.John Mancini, Eric A. Cohen, Diane Catellier, Todd E. Anderson, Gerald Barbeau, Charles Lazzam, Lawrence M. Title, Peter B. Berger, Marino Labinaz, Koon K. Teo, Christopher E. Buller, for the Total Occlusion Study of Canada (TOSCA) Investigators

    Résumé Résumé
• • ·Racial differences in outcomes of veterans undergoing percutaneous coronary interventions

    Page :309-313

    Charles Maynard, Steven M. Wright, Nathan R. Every, James L. Ritchie

    Résumé Résumé
• • ·Primary renal artery stenting: Characteristics and outcomes after 363 procedures

    Page :314-323

    Robert J. Lederman, Farrell O. Mendelsohn, Renato Santos, Harry R. Phillips, Richard S. Stack, James J. Crowley

    Résumé Résumé
• • ·Screening cardiac ultrasonographic examination in patients with suspected cardiac disease in the emergency department

    Page :324-330

    Bruce J. Kimura, Mark Bocchicchio, Casey L. Willis, Anthony N. DeMaria

    Résumé Résumé
• • ·Echocardiographic follow-up study of the Ross procedure in older versus younger patients

    Page :331-335

    Gong-Yuan Xie, Divyesh Bhakta, Mikel D. Smith

    Résumé Résumé
• • ·A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians

    Page :336-339

    Borzoo Nikpoor, Gustavo Turecki, Caroline Fournier, Pierre Théroux, Guy A. Rouleau

    Résumé Résumé
• • ·The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure

    Page :340-349

    Christoph Schalcher, Gadi Cotter, Leonardo Reisin, Osmund Bertel, Isaac Kobrin, Than-Tam Guyene, Wolfgang Kiowski

    Résumé Résumé
• • ·Predictors of costs of caring for elderly patients discharged with heart failure

    Page :350-357

    Deborah J. Wexler, Jersey Chen, Grace L. Smith, Martha J. Radford, Shlomit Yaari, W.David Bradford, Harlan M. Krumholz

    Résumé Résumé
• • ·Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy

    Page :358-362

    Masami Shimizu, Hidekazu Ino, Kazuyasu Okeie, Masato Yamaguchi, Kenshi Hayashi, Mitsuru Nagata, Hideki Itoh, Taku Iwaki, Kotaro Oe, Tetsuo Konno, Junichi Taki, Kenichi Nakajima, Hiroshi Mabuchi

    Résumé Résumé
• • ·Highlights from the American College of Cardiology Forty-Ninth Annual Scientific Sessions: March 18 to 21, 2001

    Page :363-374

    Maria Cecilia Bahit, Christopher H. Cabell, Christopher K. Dyke, G.Michael Felker, Padma Kaul, Darren K. McGuire, Donal Reddan, Mark East

    
• • ·Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease

    Page :E1

    Tamaki Kitai, Masakatsu Nishikawa, Takashi Tanigawa, Tsutomu Okinaka, Hideo Wada, Hiroshi Shiku, Yasuo Ikeda, Masaaki Ito, Naoki Isaka, Takeshi Nakano

    Résumé Résumé
• • ·The effect of pravastatin and atorvastatin on coenzyme Q10

    Page :E2

    Barry E. Bleske, Richard A. Willis, Mark Anthony, Nicole Casselberry, Meeta Datwani, Virginia E. Uhley, Stephanie G. Secontine, Michael J. Shea

    Résumé Résumé
• • ·Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: A prospective, randomized clinical trial

    Page :E3

    Christopher S. Simpson, William A. Ghali, Anthony J. Sanfilippo, Sabine Moritz, Hoshiar Abdollah

    Résumé Résumé